ARCHIVES

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

Cancer Letter Editor Wine Reporting Awards

June 11, 1999

The Lancet Oncology Issues “Expression Of Concern” Over Paper

July 23, 2010

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

New Cancer Control Projects Aimed At Upgrading Care At Community Level; 56 Contracts Anticipated

November 15, 1974